Rushdhi Rauff

Rushdhi Rauff

Auto-generated profile, based on publicly available information

Rushdhi Rauff

Department of Chemistry and Biochemistry Kent State University 1175 Risman Drive Kent OH 44242 USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2023 in ChemMedChem
Verified
Journal Article
Open access
RRRushdhi Rauff
Rushdhi Rauff
SASudeshi M Abedeera
Sudeshi M Abedeera
SSStefani Schmocker
Stefani Schmocker
JXJiale Xie
Jiale Xie
SASanjaya Abeysirigunawardena
Sanjaya Abeysirigunawardena
N6‐methyladenosine (m6A) is the most abundant nucleotide modification observed in eukaryotic mRNA. Changes in m6A levels in transcriptome are tightly correlated to expression levels of m6A methyltransferases and demethylases. Abnormal expression levels of methyltransferases and demethylases are observed in various diseases and health conditions such as cancer, male infertility, and obesity. This research explores the efficacy of m6A‐modified RNA as an anticancer drug target. We discovered a 12‐mer peptide that binds specifically to m6A‐modified RNA using phage display experiments. Our fluorescence‐based assays illustrate the selected peptide binds to methylated RNA with lower micromolar affinity and inhibit the binding of protein FTO, a demethylase enzyme specific to m6A modification. When cancer cell lines were treated with mtp1, it led to an increase in m6A levels and a decrease in cell viability. Hence our results illustrate the potential of mtp1 to be developed as a drug for cancer.